Michael J. LaBarre - Feb 20, 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
4
Date filed
2/21/2025, 06:52 PM
Previous filing
Feb 18, 2025
Next filing
Feb 24, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Award $0 +11.9K $0.00 11.9K Feb 20, 2025 Common Stock 11.9K $57.44 Direct F1
transaction HALO Restricted Stock Units Award $0 +11.2K $0.00 11.2K Feb 20, 2025 Common Stock 11.2K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.